Form 8-K - Current report:
SEC Accession No. 0001654954-24-009066
Filing Date
2024-07-17
Accepted
2024-07-17 16:16:45
Documents
15
Period of Report
2024-07-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ndra_8k.htm   iXBRL 8-K 29375
  Complete submission text file 0001654954-24-009066.txt   154400

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ndra-20240715.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndra-20240715_lab.xml EX-101.LAB 14667
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ndra-20240715_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndra-20240715_pre.xml EX-101.PRE 9275
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ndra-20240715_def.xml EX-101.DEF 2099
17 EXTRACTED XBRL INSTANCE DOCUMENT ndra_8k_htm.xml XML 3903
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 241122426
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)